1. Home
  2. SNSE vs MFI Comparison

SNSE vs MFI Comparison

Compare SNSE & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • MFI
  • Stock Information
  • Founded
  • SNSE 2005
  • MFI 2002
  • Country
  • SNSE United States
  • MFI Hong Kong
  • Employees
  • SNSE N/A
  • MFI N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • MFI
  • Sector
  • SNSE Health Care
  • MFI
  • Exchange
  • SNSE Nasdaq
  • MFI NYSE
  • Market Cap
  • SNSE 9.3M
  • MFI 8.2M
  • IPO Year
  • SNSE 2021
  • MFI 2024
  • Fundamental
  • Price
  • SNSE $0.34
  • MFI $2.19
  • Analyst Decision
  • SNSE Strong Buy
  • MFI
  • Analyst Count
  • SNSE 4
  • MFI 0
  • Target Price
  • SNSE $4.25
  • MFI N/A
  • AVG Volume (30 Days)
  • SNSE 150.3K
  • MFI 2.0M
  • Earning Date
  • SNSE 05-06-2025
  • MFI 06-17-2025
  • Dividend Yield
  • SNSE N/A
  • MFI N/A
  • EPS Growth
  • SNSE N/A
  • MFI N/A
  • EPS
  • SNSE N/A
  • MFI N/A
  • Revenue
  • SNSE N/A
  • MFI $3,358,264.00
  • Revenue This Year
  • SNSE N/A
  • MFI N/A
  • Revenue Next Year
  • SNSE N/A
  • MFI N/A
  • P/E Ratio
  • SNSE N/A
  • MFI N/A
  • Revenue Growth
  • SNSE N/A
  • MFI N/A
  • 52 Week Low
  • SNSE $0.25
  • MFI $0.51
  • 52 Week High
  • SNSE $0.87
  • MFI $3.13
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 50.22
  • MFI N/A
  • Support Level
  • SNSE $0.31
  • MFI N/A
  • Resistance Level
  • SNSE $0.33
  • MFI N/A
  • Average True Range (ATR)
  • SNSE 0.04
  • MFI 0.00
  • MACD
  • SNSE 0.01
  • MFI 0.00
  • Stochastic Oscillator
  • SNSE 75.25
  • MFI 0.00

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via the internet or a platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

Share on Social Networks: